The store will not work correctly when cookies are disabled.
N-(4-(3-Bromo-5-methylphenyl)-5-(pyridin-4-yl)thiazol-2-yl)nicotinamide
ID: ALA5081520
PubChem CID: 166629521
Max Phase: Preclinical
Molecular Formula: C21H15BrN4OS
Molecular Weight: 451.35
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(Br)cc(-c2nc(NC(=O)c3cccnc3)sc2-c2ccncc2)c1
Standard InChI: InChI=1S/C21H15BrN4OS/c1-13-9-16(11-17(22)10-13)18-19(14-4-7-23-8-5-14)28-21(25-18)26-20(27)15-3-2-6-24-12-15/h2-12H,1H3,(H,25,26,27)
Standard InChI Key: BYCAMNPIFUUMNF-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
44.8904 -4.7215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.8893 -5.5452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.6015 -5.9583 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
46.3153 -5.5447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.3124 -4.7179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.5997 -4.3127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.1785 -4.3131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.1783 -3.4918 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.4668 -4.7219 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.7590 -4.3134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.6733 -3.4972 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
41.8698 -3.3275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4614 -4.0395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.0125 -4.6465 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.5382 -2.5795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.0242 -1.9140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.6882 -1.1639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.8705 -1.0782 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.3899 -1.7485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7245 -2.4959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.6466 -4.1262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1624 -3.4594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3463 -3.5447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0134 -4.2961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5027 -4.9631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3171 -4.8745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8661 -2.8794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1690 -5.7150 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
7 8 2 0
7 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 10 2 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
12 15 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
13 21 1 0
23 27 1 0
25 28 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 451.35 | Molecular Weight (Monoisotopic): 450.0150 | AlogP: 5.59 | #Rotatable Bonds: 4 |
Polar Surface Area: 67.77 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 10.98 | CX Basic pKa: 4.02 | CX LogP: 4.93 | CX LogD: 4.93 |
Aromatic Rings: 4 | Heavy Atoms: 28 | QED Weighted: 0.44 | Np Likeness Score: -1.71 |
References
1. Suresh RR, Gao ZG, Salmaso V, Chen E, Campbell RG, Poe RB, Liston TE, Jacobson KA.. (2022) Selective A3 Adenosine Receptor Antagonist Radioligand for Human and Rodent Species., 13 (4.0): [PMID:35450351] [10.1021/acsmedchemlett.1c00685] |